• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《在恶性疟原虫地图不断缩小的时代中的间日疟原虫》

Plasmodium vivax in the Era of the Shrinking P. falciparum Map.

机构信息

Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Global Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia; Internal Medicine Services, Ballarat Health Services, Ballarat, Victoria, Australia.

出版信息

Trends Parasitol. 2020 Jun;36(6):560-570. doi: 10.1016/j.pt.2020.03.009. Epub 2020 Apr 22.

DOI:10.1016/j.pt.2020.03.009
PMID:32407682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7297627/
Abstract

Plasmodium vivax is an important cause of malaria, associated with a significant public health burden. Whilst enhanced malaria-control activities have successfully reduced the incidence of Plasmodium falciparum malaria in many areas, there has been a consistent increase in the proportion of malaria due to P. vivax in regions where both parasites coexist. This article reviews the epidemiology and biology of P. vivax, how the parasite differs from P. falciparum, and the key features that render it more difficult to control and eliminate. Since transmission of the parasite is driven largely by relapses from dormant liver stages, its timely elimination will require widespread access to safe and effective radical cure.

摘要

间日疟原虫是疟疾的重要病因之一,对公共卫生造成了重大负担。虽然强化疟疾控制活动已成功降低了许多地区的恶性疟原虫疟疾发病率,但在同时存在这两种寄生虫的地区,间日疟原虫疟疾的比例持续上升。本文综述了间日疟原虫的流行病学和生物学特性,包括其与恶性疟原虫的区别,以及导致其更难以控制和消除的关键特征。由于该寄生虫的传播主要是由休眠肝期的复发驱动的,因此需要广泛获得安全有效的根治方法来及时消除它。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/75f3d1fd90e5/EMS86562-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/f4c56d482cb4/EMS86562-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/ff8d0acd1574/EMS86562-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/eefeab622cf6/EMS86562-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/75f3d1fd90e5/EMS86562-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/f4c56d482cb4/EMS86562-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/ff8d0acd1574/EMS86562-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/eefeab622cf6/EMS86562-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9973/7297627/75f3d1fd90e5/EMS86562-f004.jpg

相似文献

1
Plasmodium vivax in the Era of the Shrinking P. falciparum Map.《在恶性疟原虫地图不断缩小的时代中的间日疟原虫》
Trends Parasitol. 2020 Jun;36(6):560-570. doi: 10.1016/j.pt.2020.03.009. Epub 2020 Apr 22.
2
UK malaria treatment guidelines 2016.《2016年英国疟疾治疗指南》
J Infect. 2016 Jun;72(6):635-649. doi: 10.1016/j.jinf.2016.02.001. Epub 2016 Feb 12.
3
[Role of primaquine in malaria control and elimination in French-speaking Africa].[伯氨喹在非洲法语区疟疾控制与消除中的作用]
Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17.
4
Plasmodium vivax Malaria among military personnel, French Guiana, 1998-2008.1998-2008 年法属圭亚那军人中的间日疟原虫疟疾。
Emerg Infect Dis. 2011 Jul;17(7):1280-2. doi: 10.3201/eid1707.100009.
5
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA).在疟疾流行地区降低恶性疟感染后感染间日疟的风险:一项随机对照试验(PRIMA)
Trials. 2022 May 18;23(1):416. doi: 10.1186/s13063-022-06364-z.
6
The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand.疟原虫的共存:泰国恶性疟和间日疟的相关见解
Trends Parasitol. 2004 Jul;20(7):333-9. doi: 10.1016/j.pt.2004.05.004.
7
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.在恶性疟原虫和间日疟原虫流行地区的恶性疟原虫疟疾患者中采用伯氨喹根治(PRIMA):一项多中心、开放性标签、优效性随机对照试验。
Lancet. 2023 Dec 2;402(10417):2101-2110. doi: 10.1016/S0140-6736(23)01553-2. Epub 2023 Nov 15.
8
Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar.缅甸克耶邦无症状疟原虫感染对疟疾传播的贡献。
J Infect Dis. 2019 Apr 16;219(9):1499-1509. doi: 10.1093/infdis/jiy686.
9
Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.间日疟原虫与恶性疟原虫混合感染的血液期动态变化及临床意义
Am J Trop Med Hyg. 1999 Sep;61(3):367-74. doi: 10.4269/ajtmh.1999.61.367.
10
Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis.疟原虫感染后感染间日疟原虫的风险:系统评价和荟萃分析。
Lancet Infect Dis. 2019 Jan;19(1):91-101. doi: 10.1016/S1473-3099(18)30596-6.

引用本文的文献

1
Prevalence of asymptomatic non-falciparum and falciparum malaria in the 2014-15 Rwanda Demographic Health Survey.2014 - 15年卢旺达人口与健康调查中无症状非恶性疟和恶性疟的患病率。
PLoS One. 2025 Sep 11;20(9):e0330480. doi: 10.1371/journal.pone.0330480. eCollection 2025.
2
Hybrid Capsule Network for precise and interpretable detection of malaria parasites in blood smear images.用于在血涂片图像中精确且可解释地检测疟原虫的混合胶囊网络。
Front Cell Infect Microbiol. 2025 Aug 8;15:1615993. doi: 10.3389/fcimb.2025.1615993. eCollection 2025.
3
Slide positivity, trends, and risk factors of febrile Plasmodium vivax malaria along the Thailand-Myanmar border, 2018-2023.

本文引用的文献

1
The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study.印度尼西亚巴布亚复发性疟疾的发病和死亡风险:一项回顾性队列研究。
BMC Med. 2020 Feb 20;18(1):28. doi: 10.1186/s12916-020-1497-0.
2
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.他非诺喹用于疟疾的根治和预防:检测葡萄糖-6-磷酸脱氢酶缺乏症的重要性
Med J Aust. 2020 Mar;212(4):152-153.e1. doi: 10.5694/mja2.50474. Epub 2020 Feb 9.
3
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos.
2018 - 2023年泰国-缅甸边境间发热性间日疟原虫疟疾的玻片阳性率、趋势及风险因素
Infect Dis Poverty. 2025 Aug 6;14(1):82. doi: 10.1186/s40249-025-01350-4.
4
Navigating parasite antigen genetic diversity in the design of serological exposure markers for malaria.疟疾血清学暴露标志物设计中寄生虫抗原遗传多样性的应对策略
bioRxiv. 2025 Jul 8:2025.07.07.663616. doi: 10.1101/2025.07.07.663616.
5
High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of Plasmodium vivax malaria in Indonesia and Papua New Guinea: the SCOPE implementation study protocol.印度尼西亚和巴布亚新几内亚采用高剂量短疗程伯氨喹啉并在葡萄糖-6-磷酸脱氢酶(G6PD)检测后用于间日疟原虫疟疾根治的研究:SCOPE实施研究方案
BMC Infect Dis. 2025 Jul 16;25(1):922. doi: 10.1186/s12879-025-11109-9.
6
Rapid detection of G6PD deficiency SNPs using a novel amplicon-based MinION Sequencing Assay.使用基于扩增子的新型MinION测序分析法快速检测葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症单核苷酸多态性
bioRxiv. 2025 Jun 24:2025.06.23.661218. doi: 10.1101/2025.06.23.661218.
7
Trend of malaria parasites infection in Ethiopia along an international border: a Bayesian spatio-temporal study.埃塞俄比亚国际边境沿线疟原虫感染趋势:一项贝叶斯时空研究。
Infect Dis Poverty. 2025 Jul 11;14(1):66. doi: 10.1186/s40249-025-01320-w.
8
Asymptomatic/submicroscopic infection: A systematic review and META-analysis on the hidden challenge for preventing -establishment of malaria transmission.无症状/亚微观感染:关于预防疟疾传播面临的隐性挑战的系统评价与荟萃分析
Parasite Epidemiol Control. 2025 Jun 15;30:e00442. doi: 10.1016/j.parepi.2025.e00442. eCollection 2025 Aug.
9
Acceptability and feasibility of glucose-6-phosphate dehydrogenase (G6PD) testing using SD Biosensor by village malaria workers in Cambodia: a qualitative study.柬埔寨乡村疟疾防治人员使用SD生物传感器进行葡萄糖-6-磷酸脱氢酶(G6PD)检测的可接受性和可行性:一项定性研究
BMJ Glob Health. 2025 Jun 16;10(6):e019615. doi: 10.1136/bmjgh-2025-019615.
10
Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting report.与亚太国家国家疟疾规划负责人共同试用选项评估工具包:会议报告
Malar J. 2025 Jun 12;24(1):187. doi: 10.1186/s12936-025-05432-4.
在缅甸、越南、柬埔寨和老挝,间日疟原虫和恶性疟原虫无症状感染后继发间日疟原虫感染的概率。
Malar J. 2019 Dec 30;18(1):449. doi: 10.1186/s12936-019-3087-1.
4
Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin.来自巴西亚马逊流域的 2 至 14 岁间感染间日疟原虫的疟疾患者使用氯喹治疗的剂量。
Malar J. 2019 Dec 21;18(1):439. doi: 10.1186/s12936-019-3072-8.
5
Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.Access Bio/CareStart 快速诊断检测葡萄糖-6-磷酸脱氢酶缺乏症的性能:系统评价和荟萃分析。
PLoS Med. 2019 Dec 13;16(12):e1002992. doi: 10.1371/journal.pmed.1002992. eCollection 2019 Dec.
6
Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.疟疾控制干预措施对巴布亚新几内亚儿童中恶性疟原虫和间日疟原虫感染的差异影响。
BMC Med. 2019 Dec 9;17(1):220. doi: 10.1186/s12916-019-1456-9.
7
Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019.2019 年美国使用他非诺喹预防和抗复发性疟疾的指南。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1062-1068. doi: 10.15585/mmwr.mm6846a4.
8
Declining Burden of in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure.1995 年至 2016 年在全面普那喹处方根治前,泰国西北部人群中的负担下降。
Am J Trop Med Hyg. 2020 Jan;102(1):147-150. doi: 10.4269/ajtmh.19-0496.
9
Early and late mortality after malaria in young children in Papua, Indonesia.印度尼西亚巴布亚地区幼儿疟疾的早晚期死亡率。
BMC Infect Dis. 2019 Oct 30;19(1):922. doi: 10.1186/s12879-019-4497-y.
10
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.双氢青蒿素-哌喹与青蒿琥酯-咯萘啶联用和不联用伯氨喹预防间日疟复发的疗效:系统评价和个体患者数据分析荟萃分析。
PLoS Med. 2019 Oct 4;16(10):e1002928. doi: 10.1371/journal.pmed.1002928. eCollection 2019 Oct.